Physician profile
Franz Murphy
NPI 1194953059
$4,744.61
in general payments reported to CMS, 2019-2025
29 companies · $955 in 2025
The $955 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $12.29 · 2021: $168 · 2022: $744 · 2023: $1,106 · 2024: $688 · 2025: $955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,178 · Travel and Lodging: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.23 |
| Travel and Lodging | $570.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $1,454.34 | 2019-2025 | Afx2 Bifurcated Endograft System, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $1,141.88 | 2022-2025 | Abre, In.Pact Admiral, Closurefast |
| Abbott Laboratories | $405.90 | 2023-2025 | Esprit, Diamondback Peripheral, Xact |
| Musculoskeletal Transplant Foundation INC. | $265.64 | 2022 | |
| W. L. Gore & Associates, INC. | $258.29 | 2019 | |
| Inari Medical, INC. | $215.95 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $174.21 | 2022-2023 | Diamondback Peripheral |
| Cook Medical LLC | $121.64 | 2025 | Lunderquist |
| Stryker Corporation | $117.24 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $113.56 | 2021 | |
| Integra Lifesciences Corporation | $76.60 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $42.33 | 2025 | Puraply Wound Matrix |
| Amgen INC. | $37.74 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $32.91 | 2024 | Rotarexs 6 F X 135 Cm, Venovo |
| Lemaitre Vascular, INC. | $32.01 | 2020-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $28.41 | 2025 | Camzyos |
| Siemens Medical Solutions USA, INC. | $24.60 | 2021 | |
| Polynovo North America LLC | $23.11 | 2025 | Novosorb Btm |
| Genzyme Corporation | $19.64 | 2024 | |
| Hikma Pharmaceuticals USA | $19.23 | 2025 | Ryaltris |
| Actelion Pharmaceuticals US, INC. | $18.70 | 2022 | |
| Solventum Corporation | $18.01 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Merck Sharp & Dohme LLC | $16.91 | 2022 | |
| Boston Scientific Corporation | $16.74 | 2021 | |
| Pfizer INC. | $16.57 | 2024 | |
| Angiodynamics, INC. | $15.98 | 2024 | Auryon Laser System 100-120 Vac |
| Terumo Medical Corporation | $15.48 | 2019 | |
| Chiesi USA, INC. | $15.25 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Franz Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.